UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(X) Quarterly Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
For Quarterly Period Ended January 31, 1998
( ) Transition Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
For the transition period from ________________ to _______________
Commission File Number 1-8597
The Cooper Companies, Inc.
(Exact name of registrant as specified in its charter)
Delaware 94-2657368
(State or other jurisdiction (I.R.S. Employer
of incorporation or Identification No.)
organization)
6140 Stoneridge Mall Rd., Suite 590, Pleasanton, CA 94588
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code
(510) 460-3600
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No
--- ---
Indicate the number of shares outstanding of each of issuer's classes of common
stock, as of the latest practicable date.
Common Stock, $.10 par value 14,870,278 Shares
Class Outstanding at
February 27, 1998
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
INDEX
Page No.
--------
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Condensed Statements of
Income - Three Months Ended
January 31, 1998 and 1997 3
Consolidated Condensed Balance Sheets -
January 31, 1998 and October 31, 1997 4
Consolidated Condensed Statements
of Cash Flows - Three Months
Ended January 31, 1998 and 1997 5
Notes to Consolidated Condensed
Financial Statements 6
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of
Operations 14
PART II. OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K 20
Signature 21
Index of Exhibits 22
2
PART I. FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Income
(In thousands, Except for Earnings Per Share)
(Unaudited)
Three Months Ended
January 31,
1998 1997
---- ----
Net sales of products $29,384 $17,027
Net service revenue 13,454 11,349
------- -------
Net operating revenue 42,838 28,376
------- -------
Cost of products sold 11,277 5,031
Cost of services provided 12,717 10,682
Selling, general and administrative
expense 11,714 7,946
Research and development expense 456 324
Amortization of intangibles 763 288
------- -------
Income from operations 5,911 4,105
------- -------
Interest expense 1,150 1,229
Other income, net 795 20
------- -------
Income before income taxes 5,556 2,896
(Benefit of) income taxes (437) (414)
------- -------
Net income $ 5,993 $ 3,310
======= =======
Earnings per share:
Basic $ 0.40 $ 0.28
======= =======
Diluted $ 0.39 $ 0.28
======= =======
Number of shares used to compute
earnings per share:
Basic 14,808 11,676
------- -------
Diluted 15,354 11,920
------- -------
See accompanying notes.
3
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Condensed Balance Sheets
(In thousands)
(Unaudited)
January 31, October 31,
1998 1997
---------- -----------
ASSETS
Current assets:
Cash and cash equivalents $ 8,757 $ 18,249
Trade receivables, net 38,158 27,469
Inventories 25,835 15,096
Other current assets 10,117 7,755
-------- --------
Total current assets 82,867 68,569
-------- --------
Property, plant and equipment at cost 73,520 56,578
Less, accumulated depreciation and
amortization 20,742 17,055
-------- --------
52,778 39,523
-------- --------
Goodwill and other intangibles, net 85,543 36,698
Deferred tax asset 26,548 26,182
Other assets 3,617 4,326
-------- --------
$251,353 $175,298
======== ========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts and notes payable $ 10,680 $ 7,907
Current portion long-term debt 1,472 438
Accrued income taxes 13,232 9,134
Other current liabilities 17,787 16,138
-------- --------
Total current liabilities 43,171 33,617
-------- --------
Long-term debt 63,806 9,125
Other noncurrent liabilities 25,598 21,023
-------- --------
Total liabilities 132,575 63,765
-------- --------
Commitments and Contingencies (see Note 6)
Stockholders' equity:
Common stock, $.10 par value 1,485 1,480
Additional paid-in capital 250,840 249,213
Other equity (1,111) (731)
Accumulated deficit (132,436) (138,429)
-------- --------
Total stockholders' equity 118,778 111,533
-------- --------
$251,353 $175,298
======== ========
See accompanying notes.
4
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Condensed Statements of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended
January 31,
1998 1997
-------- --------
Net cash used by operating
activities $ (7,035) $ (2,252)
-------- --------
Cash flows from investing activities:
Acquisitions of businesses (23,476) --
Purchases of property, plant and
equipment (2,362) (2,234)
Investment in escrow funds -- (1,100)
-------- --------
Net cash used by investing activities (25,838) (3,334)
-------- --------
Cash flows from financing activities:
Proceeds from line of credit, net 11,000 1,529
Proceeds (payments) of long-term debt 17,729 (190)
Payment of Unimar Notes (4,155) --
Other (1,055) 46
-------- --------
Net cash provided by financing activities 23,519 1,385
-------- --------
Effect of exchange rate changes on cash and
cash equivalents (138) --
-------- --------
Net decrease in cash and cash equivalents (9,492) (4,201)
Cash and cash equivalents - beginning of
period 18,249 6,837
-------- --------
Cash and cash equivalents - end of period $ 8,757 $ 2,636
======== ========
Supplemental disclosure of noncash
investing and financing activities:
Acquisitions (see Note 4):
Fair value of assets acquired $ 81,613
Less:
Cash paid (23,476)
Company stock issued (1,492)
Notes issued (28,009)
--------
Liabilities assumed and acquisition
costs accrued $ 28,636
========
See accompanying notes.
5
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)
Note 1. General
The Cooper Companies, Inc., and its subsidiaries (the "Company") develop,
manufacture and market healthcare products, including a range of daily, flexible
and extended wear contact lenses and diagnostic and surgical instruments and
equipment. The Company also provides healthcare services through the ownership
of psychiatric facilities and by providing outpatient and other ancillary
services.
During interim periods, the Company follows the accounting policies in its Form
10-K filed with the Securities and Exchange Commission. Readers are encouraged
to refer to this and to the Company's Annual Report to Stockholders for the
fiscal year ended October 31, 1997 when reviewing this Form 10-Q. The quarterly
results in this report do not necessarily indicate results expected for
subsequent quarters.
In Management's opinion, the accompanying unaudited consolidated condensed
financial statements contain all adjustments necessary to present fairly the
Company's consolidated financial position as of January 31, 1998 and October 31,
1997 and the consolidated results of its operations and its consolidated cash
flows for the three months ended January 31, 1998 and 1997. Adjustments consist
only of normal recurring items except for $800,000 and $290,000 reductions to
the deferred tax asset valuation allowance recorded in the first quarter of 1998
and 1997, respectively, based on Management's belief that the Company's future
results will continue to compare favorably with those of the prior year.
The Company adopted Statement of Financial Accounting Standards No. 128,
"Earnings Per Share" ("FAS 128") in the first quarter of 1998. In accordance
with the provisions of FAS 128, earnings per share ("EPS") is determined by
using the weighted average number of common shares for Basic EPS, and adding
common share equivalents (stock warrants and stock options) outstanding during
the period (except where antidilutive) to determine Diluted EPS. All prior
period EPS amounts have been restated to reflect this adoption. (See Note 5.)
6
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Continued
(Unaudited)
Note 2. Inventories
January 31, October 31,
1998 1997
------- -------
(In thousands)
Raw materials $ 3,919 $ 2,748
Work-in-process 2,349 1,277
Finished goods 19,567 11,071
------- -------
$25,835 $15,096
======= =======
Inventories are stated at the lower of cost, determined on a first in, first out
or average cost basis, or market.
Note 3. Long-Term Debt
Long-term debt consists of the following:
January 31, October 31,
1998 1997
-------- --------
(In thousands)
Promissory notes - Aspect $27,218 $ --
Midland Bank 17,152 --
KeyBank Line of Credit 11,000 --
Promissory note - Wesley-Jessen
Corporation ("W-J") 1,548 1,517
County of Monroe Industrial
Development Agency ("COMIDA")
Bond 2,955 2,975
Other 5,405 916
Promissory notes- Unimar -- 4,155
------- ------
65,278 9,563
Less current installments 1,472 438
------- ------
$63,806 $ 9,125
======= =======
Promissory Notes - Aspect
The Aspect promissory notes, due December 2, 2002, were issued to former
shareholders of Aspect in conjunction with the December 1997 acquisition of
Aspect Vision Care Limited ("Aspect"). (See Note 4.) Aspect promissory notes are
denominated in Pounds Sterling (approximately 'L'16.7 million). Interest accrues
at a rate of 8% per annum and is payable in cash generally on the last day of
each October. The notes are secured by the shares of Aspect Vision Holdings
and are guaranteed by the Company. Upon the occurrence of certain events
of default as set out in the purchase agreement, the note holders may demand
immediate repayment.
7
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Continued
(Unaudited)
KeyBank Line of Credit
The KeyBank Line of Credit (the "Revolver") is a $50 million senior secured
revolving credit facility with KeyBank National Association as agent for itself
and the other members of the facility. The Revolver matures September 11, 2002.
Interest on borrowings is paid quarterly at rates ranging from 0.5% to 2% over
the London Interbank Offered Rates ("LIBOR") depending on certain financial
ratios. Such rate may be floating or fixed at the Company's option. In the first
quarter of 1998, interest rates ranged from 6.1% to 6.4%. The Company pays an
annual commitment fee of 0.375% of the unused portion of the Revolver.
Borrowings under the Revolver are secured by a first security interest in all of
the assets of the Company and guaranteed by the subsidiaries of the Company.
During the term of the Revolver, the Company may borrow, repay and re-borrow up
to $50 million subject to voluntary reductions.
Mandatory prepayments will be required to repay outstanding amounts and
permanently reduce the total commitment amount available under certain
circumstances when the Company obtains additional debt. Certain prepayments are
subject to penalties.
The Revolver contains various covenants, including maintenance of certain ratios
and transaction limitations requiring approval of the lenders.
Midland Bank
The Aspect acquisition (see Note 4) was partially funded by a 'L'10.5 million
loan from Midland Bank plc, due November 27, 2002. The Midland loan is secured
by a Letter of Credit in its favor from KeyBank National Association. The amount
of such Letter of Credit reduces the available credit under the Revolver.
Interest on the Midland loan is 20 basis points over Sterling LIBOR and is
adjusted quarterly. In addition, the Company pays an annual Letter of Credit fee
of 1% of the balance of the Midland loan to KeyBank. At January 31, 1998, the
interest rate in effect was 7.9%. On March 13, 1998, the Company converted the
denomination of the Midland loan to U.S. dollars.
8
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Continued
(Unaudited)
Unimar Promissory Notes
In April 1996, Cooper Healthcare Group, Inc. (a subsidiary of the Company)
acquired Unimar, Inc. and issued promissory notes for $4 million principal
amount, bearing an interest rate of 12% per annum, maturing April 1999. The
principal and interest outstanding on the promissory notes were repaid in the
first quarter 1998.
Economic Hedges to Manage the Risks of Fluctuations in Foreign Exchange and
Interest Rates
A portion of the Company's debt is denominated in Pounds Sterling ("Sterling").
Accordingly, the Company is exposed to fluctuations in Sterling exchange rates.
The Company has entered into forward currency contracts to hedge most of the
Sterling debt, and has entered into an interest rate swap to fix the interest
rate on the Midland loan at 6.19% per annum.
Note 4. Acquisitions
Aspect Acquisition
In December 1997, the Company, through its wholly-owned subsidiary Aspect Vision
Holding Ltd. ("Holdings"), acquired Aspect Vision Care Limited and affiliates
("Aspect"), a privately-held manufacturer of high quality contact lenses sold
primarily in the United Kingdom and other European countries. Aspect is an
English company having the Pound Sterling as its functional currency. Holdings
functional currency is the U.S. dollar. The results of Aspect and Holdings are
included in CooperVision, Inc. ("CVI").
The cost of the acquisition is approximately $51 million ($20 million in cash,
$1.5 million for 38,000 shares of the Company's common stock and $28 million in
8% five-year notes to the selling shareholders) plus an additional amount after
approximately three years based on performance of Aspect over that period. The
'L'5 million (approximately $8 million at closing) minimum amount of the
additional payment has been discounted at a rate of 8% and will accrete over
approximately three years. The cash payment was partially financed under the
Company's $50 million Revolver (see "Midland Bank" Note 3) and cash then on
hand. The acquisition has been accounted for as a purchase method. Excess of
purchase price over net assets acquired ("Goodwill") has initially been recorded
at $47.6 million pending completion of a valuation required to finalize the
allocation of the purchase price. This Goodwill is being amortized over 40
years.
9
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Continued
(Unaudited)
Anthony Galley, a director of Aspect, provided short-term funds to Aspect of
'L'500,000 in January 1998 at 9.25% annual interest rate.
The following unaudited pro forma consolidated condensed results of operations
for the quarters ended January 31, 1998 and 1997 are presented as if Aspect had
been acquired at the beginning of each period presented. The unaudited pro forma
information is not indicative of either the results of operations that would
have occurred if Aspect had been purchased during the periods presented or of
future results of the combined operations.
Amounts ($000) Quarter Ended January 31,
-------------------------
1998 1997
Pro Forma Pro Forma
--------- ---------
Revenue $46,139 $35,612
Net income $ 6,261 $ 3,946
Shares outstanding for:
Basic EPS 14,836 11,714
Diluted EPS 15,382 11,958
EPS:
Basic $ 0.42 $ 0.34
Diluted $ 0.41 $ 0.33
10
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Continued
(Unaudited)
Note 5. Earnings Per Share
Three Months Ended
January 31,
1998 1997
------- -------
Basic:
Net income $ 5,993 $ 3,310
------- -------
Weighted average common shares 14,808 11,676
------- -------
Basic earnings per share $ 0.40 $ 0.28
------- -------
Diluted:
Net income $ 5,993 $ 3,310
------- -------
Weighted average common shares 14,808 11,676
Dilutive warrants 60 41
Dilutive options 486 203
------- -------
Effect of dilutive securities 546 244
------- -------
Denominator for diluted earnings per share 15,354 11,920
------- -------
Diluted earnings per share $ 0.39 $ 0.28
------- -------
There were no antidilutive shares in the 1998 period
In the first quarter of 1997, options to purchase 50,000 shares of common stock
at $16 per share were excluded from the computation of diluted EPS because their
exercise price was greater than the average market price. Also in the first
quarter 1997, the Company had outstanding 10 5/8% Convertible Subordinated Reset
Debentures, which if converted would result in additional 619,333 shares of
common stock. Using the "if converted method" these securities were antidilutive
in the period and, therefore, were not included in the computation.
Note 6. Commitments, Contingencies and Pending Litigation
Pilkington Supply Agreement
Under the terms of a supply agreement most recently modified in 1993, the
Company agreed to purchase, by December 31, 1997, from Pilkington plc contact
lenses with an aggregate cost of approximately 'L'4.1 million. As of December
31, 1997, a commitment of 'L'1.5 million remained.
11
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Continued
(Unaudited)
The companies are currently completing another amendment to the supply agreement
under an extension of the deadline to March 31, 1998. Management expects that
the newly amended agreement, when formalized, will not contain any minimum
purchase commitments.
Royalty Agreement
In connection with the Aspect acquisition (see Note 4), the Company acquired the
obligation to pay a royalty of 7 1/2% on the first 'L'5 million net sales of
Aspect manufactured products, and 5% thereafter, with a minimum royalty of 'L'1
million a year for five years.
Environmental
In 1997, environmental consultants engaged by the Company identified a contained
groundwater contamination consisting of industrial solvents including
trichloroethane (TCA) at one of CVI's sites. In the opinion of counsel, the
solvents were released into the ground prior to the Company acquiring the
business at that site, and the area containing these chemicals is limited. The
Company intends to enter the state's remediation program and accrued $350,000
for that purpose in 1997. In the opinion of Management, the cost of remediation
will not be material when considering amounts previously accrued.
GT Labs
On October 1, 1992, GT Laboratories, Inc. filed a complaint against the Company
in the United States District Court for the Northern District of Illinois. The
Complaint alleged that the Company had breached a supply contract entered into
effective January 1, 1990 by failing to purchase the requisite number of contact
lens blanks, commonly referred to as buttons, used in the manufacture of rigid
gas permeable contact lenses. The Company denied that it had breached the
contract and asserted that the contract could be terminated if the requisite
number of buttons were not purchased, but that no further relief could be
obtained. GT Laboratories moved for Summary Judgment on its right to obtain
money damages for breach of contract. On September 13, 1993, the Court granted
GT Laboratories' Motion For Summary Judgment, and a nonfinal, non-appealable
order finding the Company liable for an undetermined amount of money damages was
entered. Because the order addressed liability only and did not include any
damage finding, the order was not final and was not appealable until such time
as damages were calculated by a jury. In January 1998, a jury trial was held in
the United States District Court for the Northern District of Illinois to
determine the amount of damages. The jury fixed the amount of damages at $1.7
million. The
12
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements, Concluded
(Unaudited)
Company intends to file post-trial motions seeking a new trial on the amount of
damages and intends to vigorously pursue an appeal on the liability findings and
any damages award once the matter is concluded in the District Court. Until the
matter is finally concluded at the District Court level, the Company is not able
to pursue its rights in the Appellate Court. In the opinion of Management, it is
more likely than not that the ultimate liability, if any, to be incurred by the
Company upon the final adjudication of this matter will not materially affect
the Company's financial position or results of operations.
13
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations
References to Note numbers below are references to the Notes to Consolidated
Condensed Financial Statements located in Item 1.
Results of Operations
Three Months Ended January 31, 1998 Compared with Three Months Ended January 31,
1997.
Net Sales of Products: Net sales of products increased by $12.4 million or 73%:
Three Months Ended
January 31, %
1998 1997 Increase
------ ------ --------
(In thousands)
CooperVision, Inc. ("CVI") $22,868 $12,232 87%
CooperSurgical, Inc. ("CSI") 6,516 4,795 36%
------- -------
$29,384 $17,027 73%
======= =======
Net sales of CVI products increased primarily as a result of the acquisition of
Aspect Vision Care ("Aspect"). (See Note 4.) Net sales from Aspect represented
over 50% of the growth and accounted for 27% of CVI sales. Increased sales of
the Preference'r' spherical and the Preference Toric'tm' product lines, which
together grew by approximately 55% over the comparable three-month period,
contributed 19% to the growth. Sales of toric lenses to correct astigmatism,
CVI's leading product group, grew 35% over the comparable three-month period and
accounted for 39% of CVI's sales. In March 1997, the Company acquired Natural
Touch'r', a line of opaque, cosmetic contact lenses that contributed over $1.1
million of sales in the first quarter of 1998. These increases were partially
offset by anticipated decreases in sales of more mature product lines.
At CSI, year-to-date net sales increased by 36% primarily due to sales of Marlow
products acquired in April 1997.
Net Service Revenue: Hospital Group of America, Inc.'s ("HGA") net service
revenue for the three-month period of $13.5 million increased by 19% over the
prior year, primarily as a result of the addition of the Mid-West Center in
April 1997, the increase in inpatient days at Hampton Hospital and additional
revenue from HGA's new Management Services Division.
14
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations, Continued
Cost of Products Sold: Gross profit (net sales of products less cost of products
sold) as a percentage of net sales of products ("margin") was:
First Quarter Margin %
----------------------
1998 1997
---- ----
CVI 64 78
CSI 53 52
Consolidated 62 70
The decrease in CVI's margin percentage for the first quarter of 1998 was due to
the acquisition of Aspect, whose products have lower margins, and increased
sales of lower margin Natural Touch'r' products purchased in March 1997.
Margin improved at CSI primarily due to cost reduction programs associated with
Unimar'r' and Marlow products.
Cost of Services Provided: Cost of services provided represents all normal
operating costs (other than financing costs and amortization of intangibles)
incurred by HGA in generating net service revenue. The result of subtracting
cost of services provided from net service revenue is $737,000, or 5%, and
$667,000, or 6%, of net service revenue in the first three months of 1998 and
1997, respectively. The increase in the rate of cost of services provided
resulted primarily from the impact of government mandated Medicare rate
reductions under the Tax Equity and Financial Responsibilities Act of 1982
("TEFRA") and certain startup costs associated with the Mid-West Center and
Management Services Division. Management is responding to TEFRA changes by
increasing the efficiency of medical service integration during psychiatric
hospitalization.
Selling, General and Administrative Expense: Selling, general and administrative
(SG&A) expense by business unit and corporate were as follows:
Three Months Ended
January 31, %
1998 1997 Increase
------ ------ --------
(In thousands)
CVI $ 8,006 $ 4,782 67%
CSI 2,171 1,798 21%
Corporate/other 1,537 1,366 13%
------- -------
$11,714 $ 7,946 47%
======= =======
15
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations, Continued
SG&A expense for the three-month period increased 47%, largely as a result of:
(1) the acquisition of Aspect in December 1997, (2) higher selling, promotion
and distribution costs at CVI, which contributed to a 37% increase in sales
(excluding Aspect) and (3) CSI expenses related primarily to the Marlow
acquisition, which contributed to CSI's 36% revenue increase.
Research and Development Expense: Research and development expense was $456,000
and $324,000 for the three-month periods ended January 31, 1998 and 1997,
respectively.
Income From Operations: As a result of the variances discussed above, income
from operations improved by $1.8 million, or 44%, from the amount reported for
the 1997 first quarter. Income (loss) from operations for each business unit and
corporate was:
Three Months Ended
January 31, Increase
1998 1997 (Decrease)
---- ---- ----------
(In thousands)
CVI $ 5,980 $ 4,430 $ 1,550
CSI 776 419 357
HGA 692 622 70
Corporate/Other (1,537) (1,366) (171)
------- ------- -------
$ 5,911 $ 4,105 $ 1,806
======= ======= =======
Interest Expense: The decrease in interest expense is primarily due to: (1) the
redemption of the Company's 10 5/8% Convertible Subordinated Reset Debentures in
April 1997 and the 10% Senior Subordinated Secured Notes in September 1997 and
(2) the payments of other debt in August and September 1997. These savings were
partially offset by interest charges associated with the KeyBank Revolver,
Midland bank loan and debt due to Aspect note holders. (See Notes 3 and 4.)
Other Income, Net: Other income, net in 1998 includes a gain of approximately
$600,000 foreign exchange, principally due to the effect of a weakening in the
Pounds Sterling exchange rate against the U.S. dollar. As a result, the U.S.
dollar amount of Sterling denominated liabilities on the Company's books was
reduced prior to such liabilities being hedged. The balance of the increase from
$20,000 in 1997 to $795,000 in 1998 is primarily reflective of additional
interest income.
16
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations, Continued
Provision for Income Taxes: The provision for federal, state and foreign taxes
of $363,000 and $91,000 for the first quarter of fiscal 1998 and 1997,
respectively, was offset by the recognition of an additional benefit of $800,000
and $300,000 for the first quarter of fiscal 1998 and 1997, respectively, from
reducing the valuation allowance against the net deferred tax assets, based on
Management's belief that the Company's future results will continue to compare
favorably with those of the prior year.
17
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations, Continued
CAPITAL RESOURCES & LIQUIDITY
In the first quarter of fiscal 1998, the Company grew significantly, primarily
through the acquisition of Aspect Vision Care ("Aspect"). Aspect has achieved
compounded growth of approximately 55% during the past three years. The
acquisition provides distribution channels for CooperVision products in European
markets and an additional range of products for CooperVision to market in North
America. The acquisition also enabled the Company to enter the biweekly and
monthly lens replacement market, the largest segment of the U.S. contact lens
market.
Operating Cash Flows: The $7 million cash used by operating activities were
significantly impacted by the Aspect acquisition. Over $3 million of one-time
payments were made by Aspect shortly after the acquisition.
The Company historically experiences operating cash uses in the first quarter.
In the first quarter of 1998, other major uses of cash were payments of $2.4
million related to settlements of disputes, approximately $2.0 million to fund
fiscal 1997 entitlements under the Company's annual bonus plans and a $2.7
million build of inventories. In the first quarter of fiscal 1997, operating
cash usage was $2.3 million, which included payments associated with settlements
of disputes of $1.8 million and payments totaling $2.0 million to fund fiscal
1996 entitlements under the Company's annual bonus plans.
Investing Cash Flows: Primary uses of cash for investing activities of $25.8
million for the three months ended January 31, 1998 included the purchase of
Aspect for approximately $21.2 million, the purchase of a Hyskon'r' product
line, a hysteroscopy fluid used by gynecologists in certain surgical procedures,
for $2.2 million and investments in property, plant and equipment of $2.4
million. The investing uses of cash for the 1997 period included purchases of
property, plant and equipment of $2.2 million and a $1 million deposit on the
acquisition of the Natural Touch line of opaque contact lenses.
Financing Cash Flows: In the first quarter of fiscal 1998, the Company obtained
$23.5 million of cash from financing activities. The financing activities
primarily related to an $11 million draw down on the KeyBank line of credit and
the Midland Bank loan of $17.7 million. The cash was primarily used to fund
investing activities, as discussed above; in addition, the Company repaid the
Unimar Promissory Notes in the amount of $4.2 million.
18
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations, Concluded
Management believes cash flow from operations will be sufficient to fund ongoing
operations, but anticipates additional financings to fund plant expansions in
Europe and other acquisitions if completed.
Year 2000: The Company has assessed its financial and operational systems and
estimates that the total cost of this program will not in the aggregate be
material. The Company will continue to modify and/or replace those systems which
may be impacted by the arrival of the year 2000.
Forward-Looking Statements: Statements in this report that are not based on
historical fact may be "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. These statements use
forward-looking terminology such as "may", "will", "expect", "estimate",
"anticipate", "continue" or similar terms.
Actual results could differ materially from those contained in the
forward-looking statements due to: major changes in business conditions and the
economy in general, loss of key members of senior management, prolonged
disruption in the operations of the Company's manufacturing facilities or
hospitals, inroads by new competitors or technologies, costs to integrate
acquisitions, potential foreign exchange exposure, decisions to invest in
research and development and other start-up projects, dilution to earnings per
share associated with acquisitions or stock issuances, regulatory issues,
unexpected changes in reimbursement rates and payor mix, environmental clean-up
costs above those already accrued, litigation, decisions to divest businesses
and factors listed from time to time in the Company's SEC reports, including the
section entitled "Business" in the Company's Annual Report on Form 10-K for the
year ended October 31, 1997.
19
PART II - OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits.
Exhibit
Number Description
------ -----------
11 Calculation of Earnings Per Share.
27 Financial Data Schedule.
(b) The Company filed the following reports on Form 8-K during the period
from November 1, 1997 to January 31, 1998.
Date of Report Item Reported
-------------- -------------
November 20, 1997 Item 5. Other Events
December 2, 1997 Item 2. Acquisition or Disposition of
Assets
December 12, 1997 Item 5. Other Events
20
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
The Cooper Companies, Inc.
-----------------------------------
(Registrant)
Date: March 13, 1998 /s/ Robert S. Weiss
-----------------------------------
Executive Vice President, Treasurer
and Chief Financial Officer
21
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Index of Exhibits
Exhibit No. Page No.
- ---------- -------
11 Calculation of Earnings Per Share.
27 Financial Data Schedule.
22
The trademark symbol shall be expressed as............................ 'tm'
The registered trademark symbol shall be expressed as................. 'r'
The British pound sterling sign shall be expressed as................. 'L'
Exhibit 11
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Calculation of Earnings Per Share
(In thousands, except per share figures)
(Unaudited)
Three Months Ended
January 31,
1998 1997
------ ------
Basic:
- ------
Net income $ 5,993 $ 3,310
------- -------
Weighted average common shares 14,808 11,676
------- -------
Basic earnings per share $ 0.40 $ 0.28
------- -------
Diluted:
- --------
Net income $ 5,993 $ 3,310
------- -------
Weighted average common shares 14,808 11,676
Dilutive warrants 60 41
Dilutive options 486 203
------- -------
Effect of dilutive securities 546 244
------- -------
Denominator for diluted earnings per share 15,354 11,920
======= =======
Dilutive earnings per share $ 0.39 $ 0.28
======= =======
23
5
1,000
3-MOS
OCT-31-1998
NOV-01-1997
JAN-31-1998
8,757
0
40,677
2,519
25,835
82,867
73,520
20,742
251,353
43,171
45,592
1,485
0
0
117,293
251,353
29,384
42,838
11,277
23,994
0
0
1,150
5,556
(437)
5,993
0
0
0
5,993
.40
.39